帕金森病患者苍白球内侧部脑深部电刺激的微毁损效应
研究纳入2014年7月至2015年11月在本院接受苍白球内侧部脑深部电刺激的36例帕金森病患者,术后32例出现微毁损效应;微毁损效应幅度与术后6个月和12个月关期UPDRSIII改善相关,微毁损效应持续时间也与关期长期改善相关,但与开期无相关性。
要点
- 36例帕金森病患者接受苍白球内侧部脑深部电刺激,术后32例出现微毁损效应。
- 微毁损效应幅度与术后6个月和12个月关期UPDRSIII改善程度相关。
- 微毁损效应持续时间与关期长期改善相关,但与开期无相关性。
核心结论
- 苍白球内侧部脑深部电刺激的微毁损效应可预测帕金森病患者长期从脑深部电刺激获益。
- 药物可能对微毁损效应产生某些矛盾性影响。
- 微毁损效应的确切机制需进一步探索。
研究设计与样本
- 2014年7月至2015年11月在本院接受苍白球内侧部脑深部电刺激的36例帕金森病患者。
- 在脑深部电刺激术前及术后24小时、1周、2周、3周、6个月和1年进行评估。
- 评估项目包括用药和不用药状态下的UPDRSIII评分、每日关期时间和每日严重运动障碍时间,并记录左旋多巴剂量及微毁损效应的幅度和持续时间。
主要发现
- 36例患者中32例出现术后微毁损效应。
- 32例出现微毁损效应的患者左旋多巴剂量从960.5 ± 257.8 mg(范围550-1550)降至910.4 ± 207.5 mg(范围550-1250)。
- 关期微毁损效应UPDRSIII幅度与术后6个月和12个月较术前脑深部电刺激改善程度相关。
- 关期微毁损效应持续时间也是脑深部电刺激长期改善的指标。
- 开期微毁损效应与脑深部电刺激改善无相关性。
局限性
- 微毁损效应的确切机制需进一步探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The micro-lesion effect (MLE) has been observed in many Parkinson's disease (PD) patients after deep brain stimulation (DBS) surgery. For subthalamic nucleus (STN) stimulation, the MLE has been reported as a predictor of the long-term efficacy of DBS. However, the research on the MLE in the globus pallidus internus (GPi) is insufficient. In this report, we conducted a study of the correlation between the MLE and improvement of GPi DBS. METHODS: From July 2014 to November 2015, 36 PD patients underwent GPi DBS in our hospital. The patients were evaluated before DBS and postoperatively at 24 h, 1 week, 2 weeks, 3 weeks, 6 months and 1 year. The evaluated items included the following: the UPDRSIII score with and without medication, off time per day and severe dyskinesia time per day. The dose of L-dopa, magnitude and duration of MLE were also recorded. RESULTS: There were 32 patients with a postoperative MLE. In these 32 cases, the dose of L-dopa decreased from 960.5 ± 257.8 mg (range, 550-1550) to 910.4 ± 207.5 mg (range, 550-1250). There is a correlation between the magnitude of the MLE in UPDRSIII and the improvement degree of DBS at 6 and 12 months compared with the preoperative findings when off medication. The duration of the MLE is also an indication of the improvement of DBS in the long term when off medication. However, there was no correlation with on medication. Compared with the preoperative state, the UPDRSIII score, off time and severe dyskinesia time had improved postoperatively. CONCLUSIONS: The MLE of GPi is a predictor of PD patients who would benefit from DBS in the long term. Medication may have some conflicting effects on the MLE. The exact mechanism of the MLE requires further exploration.
引用
- Wang Y, Li P, Gong F, et al. Micro lesion effect of the globus pallidus internus with deep brain stimulation in Parkinson's disease patients. Acta Neurochir (Wien). 2017. PMID: 28755172. doi:10.1007/s00701-017-3271-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。